Illustration of barberry and Chinese goldthread plants, two natural sources of berberine, on a teal background
October 08, 2026

Berberine: What the Evidence Shows, What It Doesn't, and Who Should Avoid It

By SciRouter Editorial Team · Last reviewed: 9 October 2026

Berberine is a natural compound from plants such as barberry, Chinese goldthread (Coptis) and goldenseal, sold as a dietary supplement[1–3]. In trials lasting 4 to 24 weeks, mostly in Chinese adults with type 2 diabetes or high cholesterol, it modestly lowered blood glucose and LDL cholesterol[1, 4]. Its effect on body weight was small or absent[5, 6].

Important: Don't stop or change a prescribed medication without talking to your prescriber.

This guide grades popular claims about berberine benefits against human trials and lists who should avoid it. Deeper pages in this series cover berberine side effects and drug interactions, berberine compared with metformin, and berberine and GLP-1 drugs such as Ozempic.

How we researched this. We searched PubMed through NCBI E-utilities and ClinicalTrials.gov on 8 October 2026, and read Europe PMC full text where it was open. We also read pages from NCCIH, LactMed, MotherToBaby, Memorial Sloan Kettering, the FDA and France's food-safety agency ANSES. We put human randomized trials and meta-analyses first. We labelled every animal or cell result by species. We cited only sources we opened and checked against PubMed or the publisher. This page cites 61 sources. SciRouter sells no berberine product and uses no affiliate links. This page is not medical advice.

The Evidence Scorecard: how strong is each berberine claim?

Berberine's best human evidence is for modest drops in blood glucose and LDL cholesterol in adults with metabolic conditions[1, 4]. Weight-loss claims go well beyond the trial data, and longevity claims rest on animal studies only[5, 7].

A randomized controlled trial (RCT) assigns people by chance to berberine or a comparison, such as a placebo. A meta-analysis pools the results of many trials. Effect sizes below are differences from placebo or control unless stated.

Claim Our verdict Effect size Human trial quality
Blood glucose Moderate Fasting glucose −0.52 mmol/L (about 9 mg/dL); HbA1c −4.48 mmol/mol (roughly 0.4 percentage points; 7 trials, 756 adults)[4]. Largest trial: HbA1c −0.99 vs −0.59 points with placebo, 1.2 g/day for 12 weeks, 409 adults[8] Meta-analyses of 20 placebo-controlled trials (1,761 adults)[4] and 37 trials (3,048 adults with type 2 diabetes)[9]. In a 2012 review, all 14 trials were from China, ran 8 to 24 weeks, and were rated generally low in quality[10]
Cholesterol and blood fats Moderate LDL −0.46 mmol/L (about 18 mg/dL); triglycerides −0.34 mmol/L (about 30 mg/dL); HDL +0.06 mmol/L[1]. A 6-month RCT: LDL −7.7 mg/dL[6]. Heart attacks and strokes were not studied[1] 18 placebo-controlled RCTs with 1,788 adults, 900 to 1,500 mg/day for 4 to 24 weeks; 15 of the 18 were in mainland China or Hong Kong[1]. Only 2 of 12 placebo-controlled trials in a 2025 review were low risk of bias in every domain[11]
Blood pressure Early: results conflict No significant change in systolic or diastolic pressure versus placebo[11]. A 2022 meta-analysis found systolic pressure about 5.5 mmHg lower than control, at low certainty[12] A 2025 meta-analysis of 12 placebo-controlled RCTs (889 adults)[11]. Older meta-analyses also accepted comparison groups other than placebo[12, 13]
Body weight Hype: small or no average loss, far below what is marketed −0.88 kg across 23 RCTs[5]; −2.07 kg across 12 RCTs[14]; −0.11 kg, not significant, across 10 trials[15]. The 6-month RCT found −1.8 kg with berberine vs −1.9 kg with placebo[6] Meta-analyses of 23, 12 and 10 trials disagree[5, 14, 15]. Best single RCT: 337 adults, double-blind, 6 months[6]
"Nature's Ozempic" Hype Berberine: 0.88 kg more weight loss than control in a 2026 meta-analysis of 23 RCTs[5]. Semaglutide 2.4 mg, in a separate 68-week trial of 1,961 adults with overweight or obesity and no diabetes: 12.7 kg more than placebo (15.3 vs 2.6 kg)[16] No published trial has tested berberine alongside a GLP-1 drug or in people stopping one[17]. As of 8 October 2026, one registered trial of a multi-ingredient supplement containing berberine, given with or without semaglutide (NCT07195994), was recruiting, with no results posted[17]
Longevity Early Animal data only: in male mice, median remaining lifespan rose from 85.5 to 154 days[18]; in worms, mean lifespan rose 27% in one lab[19] and median lifespan rose about 12% in a multi-lab test that rated the effect "positive but non-robust"[20] No human studies. A PubMed search on 8 October 2026 found 54 records and 0 RCTs[7]
Gut microbiome Early Gut bacteria and bile acids changed more than with placebo[8, 21] Two Chinese RCTs with 409 and 297 adults measured gut bacteria[8, 21]. Links to health came from secondary analyses, and in one trial everyone took an antibiotic first[8]

How to read the verdicts:

  • Strong: several large, well-run placebo-controlled human trials agree, and the effect is big enough to matter. No berberine claim reached this level.
  • Moderate: human trials show a consistent effect, but they are small, short, mostly from one country, or at risk of bias.
  • Early: the data come mainly from animals or cells, from a few small human studies with indirect measures, or from human trials that disagree.
  • Hype: the popular claim goes far beyond what human trials show.

What is berberine?

Berberine is a natural compound found in plants such as barberry, Chinese goldthread (Coptis) and goldenseal[1–3]. Today it is easy to buy as a purified supplement[1].

  • Plant sources. Barberry and Chinese goldthread have long been used in traditional herbal medicine in Asia[1]. Berberine is the major ingredient of the Chinese herb huanglian (Coptis chinensis)[22] and is also extracted from Phellodendron[13].
  • Goldenseal is not the same thing. In one study, a goldenseal root product supplied about 28.9 mg of berberine per gram, so a 3.3 g dose held about 95 mg[23]. Most berberine trials used 900 to 1,500 mg a day[1]. NCCIH notes that very little berberine may be absorbed from goldenseal taken by mouth, so berberine study results may not apply to goldenseal[2].

How does berberine work?

Researchers are not sure. In cells and rodents, berberine switched on AMPK, a cellular energy sensor, but most of what is known about how it works comes from lab and animal studies rather than people[24, 25].

AMPK (AMP-activated protein kinase) is an enzyme that senses a cell's energy level and helps control how cells use glucose and fat[24]. In diabetic mice, berberine improved glucose tolerance and lowered body weight without changing food intake[24]. In rat muscle cells grown in the lab and in isolated muscle mitochondria, berberine slowed complex I, part of the cell's energy machinery[25]. The researchers saw a similar effect with metformin and proposed this as the way berberine switched on AMPK in their experiments[25].

Other proposed routes, labelled by type of evidence:

  • Insulin release (one small human study). In a single-dose study of 15 healthy men, berberine raised insulin release when blood sugar was raised on purpose, but not at baseline[26]. Mouse work points to a potassium channel called KCNH6[26].
  • Gut bacteria and bile acids (human trial, secondary analyses). In a 12-week trial, the authors linked berberine's glucose effect to changes in gut bacteria and bile acids[8].
  • GLP-1 (mostly animal data). Berberine raised this gut hormone in rats, but did not significantly raise it in a 16-week human trial[21, 27].

What do human trials show?

Most human trials enrolled adults with type 2 diabetes or high cholesterol, lasted 4 to 24 weeks, and took place in China[1, 10]. Across them, berberine modestly lowered blood glucose and LDL cholesterol, while weight effects were small or absent[1, 4, 5].

Blood glucose

In a 2023 meta-analysis of 20 placebo-controlled trials with 1,761 adults, berberine lowered fasting glucose by 0.52 mmol/L compared with placebo[4]. In 7 of those trials (756 people), HbA1c fell by 4.48 mmol/mol[4]. HbA1c is a blood marker of average blood sugar over about three months. The fasting-glucose effect was larger in people with diabetes and in Asian populations, a pattern the authors said needs replication[4].

  • The largest trial. PREMOTE randomly assigned 409 Chinese adults newly diagnosed with type 2 diabetes to four groups[8]. For 12 weeks, they took berberine 1.2 g a day, a probiotic, both, or placebo[8]. HbA1c fell 0.99 points with berberine and 0.59 points with placebo[8].
  • A 16-week trial. In 297 Chinese adults with newly diagnosed high blood sugar, berberine 1 g a day lowered fasting glucose by 0.50 mmol/L more than placebo[21]. On its own, it did not significantly lower HbA1c[21].
  • Durability is uncertain. A 2019 meta-analysis of 28 trials looked at subgroups[28]. The glucose effect was no longer significant in trials longer than 90 days, at doses above 2 g a day, or in people over 60[28].

Cholesterol and blood fats

A 2023 meta-analysis of 18 placebo-controlled trials found that berberine lowered LDL cholesterol by 0.46 mmol/L (about 18 mg/dL) and triglycerides by 0.34 mmol/L (about 30 mg/dL)[1]. HDL cholesterol rose by 0.06 mmol/L, a rise seen in women but not men[1]. The authors called the effects small and asked for large trials that assess clinical outcomes[1].

  • Women and men. In a 12-week trial of 100 women in Hong Kong, berberine 500 mg twice daily lowered apolipoprotein B, LDL cholesterol and lipoprotein(a) compared with placebo[29]. The effects were larger than in an earlier trial in men[29].

Blood pressure

The blood-pressure evidence conflicts. In a 2025 meta-analysis of 12 placebo-controlled trials with 889 adults, berberine did not significantly change systolic or diastolic blood pressure[11].

Older meta-analyses also accepted comparison groups other than placebo[12, 13]. A 2015 meta-analysis of 27 trials included trials in people with high blood pressure[13]. In those trials, berberine plus a lifestyle intervention tended to lower blood pressure more than the lifestyle intervention alone or placebo[13]. The authors rated the overall quality of the trials as limited[13]. A 2022 meta-analysis of 20 trials (1,426 adults) found systolic pressure about 5.5 mmHg lower than in control groups, at low certainty[12].

Berberine and weight loss

The weight data are much weaker than the marketing. A 2026 meta-analysis of 23 randomized trials found an average weight difference of 0.88 kg (about 2 lb) versus control[5]. Earlier meta-analyses reported −2.07 kg across 12 trials[14] and no significant change, −0.11 kg, across 10 trials[15].

The strongest single test is the 2026 BRAVO trial[6]. It enrolled 337 adults with obesity and fatty liver but no diabetes at 11 hospitals in China[6]. For 6 months they took berberine 1 g a day or placebo, and both groups got lifestyle advice[6]. Weight fell 1.8 kg with berberine and 1.9 kg with placebo, and belly (visceral) fat and liver fat did not differ[6].

The widely quoted "5 lb in 12 weeks" figure comes from a small pilot in adults with obesity who took 500 mg three times daily[30]. Its abstract describes no placebo group, so the change cannot be credited to berberine[30].

Gut microbiome

In PREMOTE, berberine shifted the gut microbiome and blood bile acids[8]. The authors linked its glucose effect to less bile-acid conversion by one gut bacterium, Ruminococcus bromii[8]. These were secondary analyses, and every participant took the antibiotic gentamicin for a week before randomization[8].

In the 16-week trial, groups taking berberine showed larger changes in gut bacteria than the placebo group[21].

What does the research show about berberine and lifespan?

No human study has tested whether berberine affects lifespan[7]. The lifespan data come from one mouse study, a few roundworm studies and fruit-fly work[7].

How we counted. On 8 October 2026 we searched PubMed for berberine AND (lifespan OR longevity)[7]. It returned 54 records, none of them randomized controlled trials[7]. PubMed tags many reviews and human-cell studies as "humans", so we screened every title. None was a study of human lifespan[7].

Where berberine's lifespan evidence stops Four stacked boxes. Roundworms: mean lifespan 27 percent longer in one lab, and median lifespan about 12 percent longer in a multi-lab test. Fruit flies: longer lifespan, females only. Mice: median remaining lifespan 85.5 to 154 days, male mice, one lab. Humans: no lifespan studies; none of 54 PubMed records was a randomized trial. Roundworms +27% mean lifespan, one lab About +12% in a multi-lab test Fruit flies Longer lifespan Female flies only Mice Remaining lifespan 85.5 → 154 days Male mice, one lab Humans No lifespan studies 0 of 54 PubMed records were RCTs
Where berberine's lifespan evidence stops. Results in roundworms, fruit flies and mice have not been tested in people[7, 18–20, 31].
Species What was found Limits
Mice Male mice given 50 mg/kg a day by mouth from 18 months of age: median remaining lifespan rose from 85.5 to 154 days[18] Male mice, one lab, not independently repeated[18]
Roundworms (C. elegans) Mean lifespan rose 27% in one lab[19]; healthy lifespan improved at 10 µM in another[32] Worm studies, single labs
Roundworms, multi-lab test Median lifespan rose about 12% at one high concentration, an effect rated "positive but non-robust"[20] Not chosen for further study[20]
Fruit flies Longer mean, median and maximum lifespan[31] Female flies only[31]

Animal lifespan results do not tell us what happens in people. For a molecule with deeper cross-species longevity data, see our spermidine evidence review. For the human side, our article on what the longest-lived people have in common looks at the diets and habits reported among centenarians.

Which form of berberine was studied?

Large trials such as BRAVO used plain berberine hydrochloride (HCl)[6]. Newer forms raised blood berberine in small studies, often funded by their makers, but those studies measured blood levels or found no difference in glucose[33, 34].

Only a small share of swallowed berberine reaches the blood: in rats, oral bioavailability (the share of a dose that reaches the bloodstream) was 0.36% to 0.68%[35, 36]. In animal studies, gut bacteria turned berberine into dihydroberberine, a form the gut absorbed faster[37]. Dihydroberberine and phytosome products aim to raise absorption, but the main absorption studies behind them were small: 5 healthy men and 12 healthy volunteers[33, 34]. We compare study sizes, funders and doses in berberine vs dihydroberberine vs berberine phytosome.

Patches are a separate question. Searches of PubMed, Europe PMC and ClinicalTrials.gov found no human study that measured blood levels, blood sugar or weight after a berberine patch[38]. The FDA states that dietary supplements must be swallowed, so topical products are not supplements[39]. Our review of whether berberine patches work covers the skin-absorption evidence.

What doses were used in trials?

Most trials gave 900 to 1,500 mg of berberine a day for 4 to 24 weeks[1]. These are the amounts studied, not a recommendation, so agree on any dose with your clinician.

Five of the six trials below split the daily amount into two or three doses.

Study Who took part Daily dose Length Main result
PREMOTE, 2020[8] 409 adults newly diagnosed with type 2 diabetes, China 1.2 g (0.6 g twice daily before meals) 12 weeks HbA1c −0.99 vs −0.59 points with placebo
Zhang, 2008[40] 116 adults with type 2 diabetes and high blood fats, China 1.0 g 3 months HbA1c 7.5% to 6.6% in the berberine group; differed from placebo
Yin, 2008 pilot[41] 36 adults newly diagnosed with type 2 diabetes, China, randomly assigned to berberine or metformin 1.5 g (0.5 g three times daily) 13 weeks HbA1c 9.5% to 7.5% in the berberine group; similar to metformin
Ming, 2021[21] 297 adults with newly diagnosed high blood sugar, China 1 g (0.5 g twice daily) 16 weeks Fasting glucose −0.50 mmol/L vs placebo
Zhao, 2026[29] 100 women, Hong Kong 1 g (500 mg twice daily) 12 weeks Lower apolipoprotein B, LDL and lipoprotein(a) vs placebo
BRAVO, 2026[6] 337 adults with obesity and fatty liver, no diabetes, China 1 g (0.5 g twice daily) 6 months No weight difference; LDL −7.7 mg/dL vs placebo

What are the side effects and drug interactions?

Common side effects are digestive, such as constipation and diarrhea[42]. The more serious concern is drug interactions, because berberine slowed liver enzymes that clear many common medicines[43].

In the 12 placebo-controlled trials that reported them, digestive complaints affected 2% to 23% of people taking berberine and 2% to 15% of those on placebo[1]. None of the 16 trials that reported adverse events recorded a serious one with berberine[1]. In two 3-month pilot studies at 1.5 g a day, alone or with other diabetes drugs, 34.5% had temporary digestive effects, mostly in the first four weeks[41]. About one in four, all taking other diabetes drugs as well, needed a lower dose[41].

Medicine or group What studies found Evidence type
Drugs cleared by CYP3A4, CYP2D6 or CYP2C9 900 mg a day for 2 weeks slowed all three enzymes; levels of the test drug midazolam rose about 40%[43] Human study in healthy men
Cyclosporine (anti-rejection drug) Blood levels about 29% higher after 3 months in kidney-transplant recipients[44] Human randomized trial, 104 people
Tacrolimus (immunosuppressant) In a child, blood levels rose, with kidney toxicity, after berberine was added during an episode of diarrhea[3, 45] Single case report
Glucose-lowering drugs Low blood sugar is a listed risk[46]; pooled trials showed no significant rise but could not rule one out (relative risk 0.48, 95% CI 0.21 to 1.08)[9] Agency review; meta-analysis
Simvastatin and fenofibrate No noticeable change in drug levels over 7 days[47] Human study, 60 healthy adults
Metformin A goldenseal product standardized to berberine lowered metformin levels by about 23%[48] Human study of goldenseal, not purified berberine

Heart rhythm is a newer concern. Berberine blocked hERG, a potassium channel that helps the heart reset between beats, in human kidney cells and frog eggs engineered to carry the channel[49]. Three 2026 case reports described torsades de pointes, a dangerous heart rhythm, in people taking berberine, and their heart tracings improved after the supplements were stopped[50–52]. Case reports cannot prove that berberine was the cause. Our guide to berberine interactions has the full table and the case details.

Who should avoid berberine?

Berberine is not recommended during pregnancy or breastfeeding, or for newborns, children and teenagers[2, 46]. Anyone who takes prescription medicines should ask their prescriber before trying it, because berberine can change how the body clears some drugs[43].

  • Pregnant or breastfeeding people, because berberine can displace bilirubin, which may build up in a newborn's brain[22, 53, 54].
  • Children and teenagers, whom France's food-safety agency advised to avoid berberine supplements[46].
  • People taking cyclosporine, tacrolimus or other prescription medicines, because berberine raised levels of these two drugs and can interact with many others[3, 43–46].
  • People taking glucose-lowering medicines, because of the risk of low blood sugar[46].
  • People with diabetes, a liver disorder or a heart disorder, a group France's food-safety agency also advised to avoid it[46].

The evidence behind each caution, including the heart-rhythm case reports, is in our guide to berberine side effects, interactions and who should avoid it.

What about berberine and GLP-1 drugs like Ozempic?

Berberine is not a substitute for GLP-1 drugs, and in trials its average weight effect was more than ten times smaller[5, 16]. No published trial has tested berberine alongside these drugs or in people stopping them[17].

Is berberine "nature's Ozempic"? It raised GLP-1 release in rats and in lab-grown human gut cells, but a 16-week human trial found no significant difference from placebo in blood GLP-1[21, 27, 55]. Our page on how berberine compares with Ozempic, Wegovy and Zepbound sets the trial numbers side by side, covers what happened after people stopped these drugs and lists questions for your prescriber.

Is berberine as good as metformin?

Small, mostly low-quality trials found no significant difference in blood-sugar control between berberine and metformin or other oral diabetes drugs[10]. That is not proof the two are equivalent, and berberine is not a replacement for a prescribed medicine.

The best-known head-to-head pilot ran in Shanghai in 2008[41]. It analyzed 31 adults newly diagnosed with type 2 diabetes who took berberine or metformin, 0.5 g three times daily, for 13 weeks[41]. HbA1c fell by similar amounts in both groups[41]. Goldenseal, a berberine-containing herb, lowered metformin levels by about 23% in 16 healthy adults, so taking both is a question for your prescriber[48]. See what head-to-head studies of berberine and metformin found.

What should you know about berberine supplement quality?

Label amounts are not always accurate[56], and the FDA told TODAY.com in 2025 that no FDA-approved drug product contains berberine[57]. Be wary of claims of GLP-1 effects or "nature's Ozempic" results, because human trials do not support them[5, 21].

When a US lab tested 15 berberine supplements, they held on average 75% of the berberine their labels claimed, with a range of 33% to 100%[56]. A label may also give the weight of a whole complex: one 550 mg phytosome tablet held 188 mg of berberine[34]. A 2026 review of 25 "natural GLP-1" skin products found berberine among the most common ingredients and no posted certificates of analysis[58]. Our checklist for choosing a berberine supplement covers dose per capsule, third-party testing and red flags.

Get our plain-English longevity research digest

Short, sourced summaries of new longevity research, written in plain English. No product pitches. Unsubscribe anytime.

Frequently asked questions

What does berberine do in your body?

In people, berberine's best-studied effects are modest drops in blood glucose and LDL cholesterol. In meta-analyses of placebo-controlled trials, it lowered fasting glucose by 0.52 mmol/L[4] and LDL cholesterol by 0.46 mmol/L[1]. In cells and rodents, berberine switched on AMPK, an energy sensor that helps control how cells use glucose and fat[24].

Why don't doctors like berberine?

The published evidence gives four reasons for caution about berberine. Its trials were mostly small, short and from one country, and reviewers rated their quality as generally low[10, 11]. Berberine slowed liver enzymes that clear many common medicines[43]. It is not advised in pregnancy because of a possible risk to newborns[22, 46]. And 2026 case reports linked berberine with a dangerous heart rhythm, although they could not prove it was the cause[50–52].

What happens when you take berberine every day?

In trials, people took berberine every day, usually 900 to 1,500 mg for 4 to 24 weeks[1]. Fasting glucose and LDL cholesterol fell modestly compared with placebo[1, 4]. Digestive side effects such as constipation and diarrhea were common complaints[42]. Most trials lasted 6 months or less, so the effects of daily use over many years are unknown[1, 6].

Does berberine shrink belly fat?

Berberine did not shrink belly fat in the largest trial we found that measured it. In a 6-month double-blind trial of 337 adults with obesity and fatty liver, berberine 1 g a day did not reduce visceral (deep belly) fat or liver fat more than placebo[6]. Pooled trials found waist size about 1 to 3 cm smaller than with control, a small difference[11, 14].

Is berberine just turmeric?

No. Berberine is a single plant compound[59], while turmeric is a spice plant, Curcuma longa, in the ginger family[60]. Curcumin, a major component of turmeric, gives the spice its yellow color[60]. One berberine-containing plant, Berberis aristata, is known as "tree turmeric", but it belongs to the barberry genus, not the ginger family[3, 61]. Other plant sources of berberine include barberry, Oregon grape, Chinese goldthread and goldenseal[3, 61].

Does berberine improve gut health?

Berberine changed the gut bacteria of people taking it, but what that means for gut health is not clear[8, 21]. In two Chinese trials of 409 and 297 adults newly diagnosed with type 2 diabetes or high blood sugar, the berberine groups had larger shifts in gut bacteria than the placebo groups[8, 21]. In the larger trial, everyone took an antibiotic first, and digestive side effects were more common with berberine[8].

Does berberine help you live longer?

No study has shown that berberine helps people live longer. A PubMed search on 8 October 2026 found 54 records on berberine and lifespan or longevity, and none was a randomized trial[7]. Longer lifespans were reported only in animals: male mice given berberine late in life, roundworms and female fruit flies[18, 19, 31]. A multi-lab worm test rated berberine's effect positive but non-robust[20].

References

  1. Blais JE, Huang X, Zhao JV. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs. 2023. PMID: 36941490
  2. National Center for Complementary and Integrative Health (NIH). Goldenseal: Usefulness and Safety. 2025.
  3. Memorial Sloan Kettering Cancer Center. Berberine (About Herbs database). Updated 12 June 2023.
  4. Zhao JV, Huang X, Zhang J, et al. Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Nutr. 2023. PMID: 37598753
  5. Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026. PMID: 41310257
  6. Lei L, Wang B, Zhao L, et al. Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial. JAMA Netw Open. 2026. PMID: 41543854
  7. PubMed, National Library of Medicine. Search: berberine AND (lifespan OR longevity), run 8 October 2026. 2026.
  8. Zhang Y, Gu Y, Ren H, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020. PMID: 33024120
  9. Xie W, Su F, Wang G, et al. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022. PMID: 36467075
  10. Dong H, Wang N, Zhao L, et al. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012. PMID: 23118793
  11. Liu D, Zhao H, Zhang Y, et al. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Front Pharmacol. 2025. PMID: 40740996
  12. Zamani M, Zarei M, Nikbaf-Shandiz M, et al. The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis. Front Nutr. 2022. PMID: 36313096
  13. Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015. PMID: 25498346
  14. Asbaghi O, Ghanbari N, Shekari M, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2020. PMID: 32690176
  15. Xiong P, Niu L, Talaei S, et al. The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials. Complement Ther Clin Pract. 2020. PMID: 32379652
  16. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. PMID: 33567185
  17. SciRouter research log. Search of PubMed, Europe PMC and ClinicalTrials.gov for trials of berberine alongside or after GLP-1 drugs, run 8 October 2026. 2026.
  18. Dang Y, An Y, He J, et al. Berberine ameliorates cellular senescence and extends the lifespan of mice via regulating p16 and cyclin protein expression. Aging Cell. 2020. PMID: 31773901
  19. Bei Y, Wang T, Guan S. Berberine Extends Lifespan in C. elegans Through Multi-Target Synergistic Antioxidant Effects. Antioxidants (Basel). 2025. PMID: 40338239
  20. Banse SA, Sedore CA, Coleman-Hulbert A, et al. Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically diverse Caenorhabditis nematodes. Elife. 2025. PMID: 41432067
  21. Ming J, Yu X, Xu X, et al. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. Genome Med. 2021. PMID: 34365978
  22. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate. 1993. PMID: 8513024
  23. Nguyen JT, Arian CM, Tanna RS, et al. The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent: A Three-Arm Crossover Study in Adults With Type 2 Diabetes. Clin Transl Sci. 2025. PMID: 39943692
  24. Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006. PMID: 16873688
  25. Turner N, Li JY, Gosby A, et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes. 2008. PMID: 18285556
  26. Zhao MM, Lu J, Li S, et al. Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. Nat Commun. 2021. PMID: 34556670
  27. Lu SS, Yu YL, Zhu HJ, et al. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol. 2009. PMID: 18996945
  28. Liang Y, Xu X, Yin M, et al. Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocr J. 2019. PMID: 30393248
  29. Zhao JV, Chen B, Chan YH, et al. Sex-Specific Lipid, Apolipoprotein B, and Lipoprotein(a) Responses to Berberine Based on 2 Randomized Placebo-Controlled Trials. JACC Asia. 2026. PMID: 42470424
  30. Hu Y, Ehli EA, Kittelsrud J, et al. Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine. 2012. PMID: 22739410
  31. Navrotskaya VV, Oxenkrug G, Vorobyova LI, et al. Berberine Prolongs Life Span and Stimulates Locomotor Activity of Drosophila melanogaster. Am J Plant Sci. 2012. PMID: 26167392
  32. Xiao Y, Zhang L, Zhou H, et al. Berberine extends healthspan and delays neurodegenerative diseases in Caenorhabditis elegans through ROS-dependent PMK-1/SKN-1 activation. Arch Gerontol Geriatr. 2025. PMID: 39357500
  33. Moon JM, Ratliff KM, Hagele AM, et al. Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial. Nutrients. 2021. PMID: 35010998
  34. Petrangolini G, Corti F, Ronchi M, et al. Development of an Innovative Berberine Food-Grade Formulation with an Ameliorated Absorption: In Vitro Evidence Confirmed by Healthy Human Volunteers Pharmacokinetic Study. Evid Based Complement Alternat Med. 2021. PMID: 34904017
  35. Liu YT, Hao HP, Xie HG, et al. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos. 2010. PMID: 20634337
  36. Chen W, Miao YQ, Fan DJ, et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech. 2011. PMID: 21637946
  37. Feng R, Shou JW, Zhao ZX, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep. 2015. PMID: 26174047
  38. SciRouter research log. Search of PubMed, Europe PMC and ClinicalTrials.gov for human studies of berberine patches or transdermal berberine, run 8 October 2026. 2026.
  39. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. 2026.
  40. Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008. PMID: 18397984
  41. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008. PMID: 18442638
  42. Li Z, Wang Y, Xu Q, et al. Berberine and health outcomes: An umbrella review. Phytother Res. 2023. PMID: 36999891
  43. Guo Y, Chen Y, Tan ZR, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012. PMID: 21870106
  44. Wu X, Li Q, Xin H, et al. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol. 2005. PMID: 16133554
  45. Hou Q, Han W, Fu X. Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome. Eur J Clin Pharmacol. 2013. PMID: 23765408
  46. ANSES (French Agency for Food, Environmental and Occupational Health & Safety). Use of berberine-containing plants in food supplements. 2019.
  47. Li G, Zhao M, Qiu F, et al. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects. Drug Des Devel Ther. 2019. PMID: 30587933
  48. Nguyen JT, Tian DD, Tanna RS, et al. Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail. Clin Pharmacol Ther. 2021. PMID: 33174626
  49. Rodriguez-Menchaca A, Ferrer-Villada T, Lara J, et al. Block of HERG channels by berberine: mechanisms of voltage- and state-dependence probed with site-directed mutant channels. J Cardiovasc Pharmacol. 2006. PMID: 16424781
  50. Williams JM, Yadlapalli N, Franchi F. Natural Is Not Always Safe: A Case of Torsades De Pointes Induced by Berberine Supplementation. Cureus. 2026. PMID: 42488242
  51. Mesmin MP, Tweet MS, Kim SH, et al. Berberine Poisoning with Polymorphic Ventricular Tachycardia: A Case Report. Clin Pract Cases Emerg Med. 2026. PMID: 42647909
  52. Mohammadi A, Abdalla HM, Falls N, et al. Recurrent Torsades de Pointes Precipitated by Berberine Supplement. JACC Case Rep. 2026. PMID: 42684237
  53. Drugs and Lactation Database (LactMed). Goldenseal. National Institute of Child Health and Human Development. 2006 (revised 2025). PMID: 30000926
  54. MotherToBaby, Organization of Teratology Information Specialists. Berberine. MotherToBaby Fact Sheets. Fact sheet dated May 2025. PMID: 38349985
  55. Yu Y, Liu L, Wang X, et al. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol. 2010. PMID: 19945441
  56. Funk RS, Singh RK, Winefield RD, et al. Variability in Potency Among Commercial Preparations of Berberine. J Diet Suppl. 2018. PMID: 28792254
  57. TODAY.com. Do 'GLP-1 Patches' Work for Weight Loss? Doctors Warn About Trend. 2025.
  58. White CM, Tai Z, Nuzi K. Transdermal "Natural GLP-1" Dietary Supplements Violate Law and Place Patients at Risk. Ann Pharmacother. 2026. PMID: 41480958
  59. PubChem, National Center for Biotechnology Information. Berberine (CID 2353). Accessed 8 October 2026.
  60. National Center for Complementary and Integrative Health (NIH). Turmeric: Usefulness and Safety. 2025.
  61. Neag MA, Mocan A, Echeverría J, et al. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front Pharmacol. 2018. PMID: 30186157

This content is for education only and is not medical advice. Talk to your healthcare provider before starting any supplement, especially if you are pregnant, nursing, take medication, or have a medical condition.

more Blog posts

View all